Elisa Agostinetto

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Elisa Agostinetto
Jun 25, 2024, 07:12 | Blog
Elisa Agostinetto and Giuseppe Curigliano discuss the results of Destiny-Breast06
Elisa Agostinetto shared on LinkedIn: "At ASCO24 I met Prof Giuseppe Curigliano to discuss the results…
Jun 23, 2024, 02:25 | Blog
Elisa Agostinetto: Important data for patients who desire pregnancy after a diagnosis of breast cancer
Elisa Agostinetto shared a post by ESMO on X/Twitter: "Are assisted reproductive techniques safe in…
Jun 20, 2024, 11:58 | Insight
Elisa Agostinetto: A must-read for all oncologists
Elisa Agostinetto recently shared a post on X: "Published in 2023 and yet addressing a…
Jun 18, 2024, 15:34 | Blog
Elisa Agostinetto: Congrats to Matteo Lambertini for having organized a great YBO event
Elisa Agostinetto shared a post on X: “Congrats to Matteo Lambertini for having organized a great…
Jun 17, 2024, 20:15 | Insight
Elisa Agostinetto: Commentary on the updated results of DestinyBreast03
Elisa Agostinetto shared on X/Twitter: "Out commentary on the updated results of DestinyBreast03 is out…
Jun 2, 2024, 11:17 | Societies
Elisa Agostinetto: Do patients with ER-low (1-10%) tumors benefit from adjuvant ET?
Hope Rugo, Professor of Medicine and Director of Breast Oncology and Clinical Trials Education at…
May 20, 2024, 11:18 | Drugs
Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “Now…
May 19, 2024, 14:11 | Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 19, 2024, 13:38 | Insight
Elisa Agostinetto: I discussed the results of our work with Video Journal of Oncology at ESMOBreast24
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “At…
May 19, 2024, 02:10 | Societies
Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making 
Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: . "At…
All: 30 Posts: 1 - 10